genOway est membre de Lyonbiopôle

General information


- Lyon

Incorporated in: 1999/03/01

Number of employees: 100

Turnover: €9M (in 2016)

More information


Main activity

genOway is a premium service provider specializing in the design and creation of reliable and physiologically relevant, genetically modified mouse, rat and cellular models. Based on strategic alliances and exclusive technologies such as CRISPR/Cas9, HR, TET-inducible systems, FLEx, RMCE or IRES co-expression, genOway proposes time saving and cost effective strategies and designs for in vivo target evaluation, lead optimization and preclinical drug development programs (ADMET, efficacy studies).


Stock exchange listing: Alternext : 2007

Products / Services / Technologies

Strategic area of application
Medical Technologies

Application market
Immune, AutoIm & Inflam. diseases - Neurological diseases - Oncology

Therapeutics, Pharma or Biotech


En poursuivant votre navigation sur ce site, vous acceptez l'utilisation de cookies pour vous proposer des services et offres adaptés à vos centres d'intérêt. En savoir plus... Fermer